Goldman Sachs’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$22.6K Buy
2022
Q4
Sell
2022
Q3
$9K Sell
2022
Q2
$21K Sell
2022
Q1
$58K Buy
2021
Q4
$113K Sell
2021
Q3
$554K Sell
2021
Q2
$731K Hold
2021
Q1
$721K Buy